{{Rsnum
|rsid=1550117
|Gene=DNMT3A
|Chromosome=2
|position=25343038
|Orientation=plus
|GMAF=0.1309
|Gene_s=DNMT3A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 15.0 | 85.0
| HCB | 2.9 | 32.4 | 64.7
| JPT | 3.5 | 39.8 | 56.6
| YRI | 0.0 | 9.6 | 90.4
| ASW | 0.0 | 7.0 | 93.0
| CHB | 2.9 | 32.4 | 64.7
| CHD | 2.8 | 35.8 | 61.5
| GIH | 1.0 | 13.9 | 85.1
| LWK | 0.9 | 11.9 | 87.2
| MEX | 10.3 | 37.9 | 51.7
| MKK | 1.3 | 19.9 | 78.8
| TSI | 1.0 | 15.7 | 83.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23666104
|Title=DNMT1, DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}